WuXi AppTec rides the last 2018 IPO wave in HK

Wave 230x150
By Christie Ou
29 Nov 2018

WuXi AppTec’s Hong Kong IPO is set to be yet another test case of investor appetite for biotechnology names, as the company kicked off its chunky HK$7.5bn ($958m) flotation this week. With all eyes on the offering, its performance in both primary and secondary can have ramifications for other listing hopefuls in the city, writes Christie Ou.

The firm’s share sale is being sponsored by Morgan Stanley as the left lead, together with Huatai Financial and Goldman Sachs. China Merchants Securities and UBS are also the global co-ordinators and bookrunners along with the sponsors, while BOC International, China Renaissance and CLSA are the bookrunners. 

Wuxi ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial